SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that Andy LaFrence, vice president of finance
and chief financial officer, will make a presentation to the investment
community at the Canaccord Genuity Medical Technology & Diagnostics
Conference on Thursday, November 14, 2013, at 1 p.m. CT (2 p.m. ET) in
New York City.
A live audio webcast of the presentation will be available by going to
the investor relations portion of the Company’s website at www.surmodics.com
and clicking on the webcast icon. At the end of the day on Thursday,
November 14, the audio and slide presentation will be archived on the
Company’s website for 90 days.
About SurModics, Inc.
SurModics’ mission is to exceed our
customers’ expectations and enhance the well-being of patients by
providing the world’s foremost, innovative surface modification
technologies and in vitro diagnostic chemical components. The
Company partners with the world’s leading and emerging medical device,
diagnostic and life science companies to develop and commercialize
innovative products designed to improve patient diagnosis and treatment.
Core offerings include surface modification coating technologies that
impart lubricity, prohealing, and biocompatibility capabilities; and
components for in vitro diagnostic test kits and microarrays.
SurModics is headquartered in Eden Prairie, Minnesota. For more
information about the Company, visit www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
Copyright Business Wire 2013